We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
Cap. Flow
+$8.92M
Cap. Flow %
0.03%
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$92.9M
2
AMZN icon
Amazon
AMZN
+$62.6M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.3M
4
VMEO
Vimeo
VMEO
+$33.1M
5
UNH icon
UnitedHealth
UNH
+$28M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.9M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$43.5M
3
HUM icon
Humana
HUM
+$36.6M
4
VIPS icon
Vipshop
VIPS
+$35.6M
5
BN icon
Brookfield
BN
+$24M

Sector Composition

Rank Sector Weight
1 Financials 41.6%
2 Technology 16.13%
3 Healthcare 10.46%
4 Consumer Discretionary 9.11%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RWO icon
1476
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$3K ﹤0.01%
60
+44
+275% +$2.35K
SII
1477
Sprott
SII
$2.65B
$3K ﹤0.01%
100
– –
SPHD icon
1478
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
$3K ﹤0.01%
90
– –
STOK icon
1479
Stoke Therapeutics
STOK
$1.82B
$3K ﹤0.01%
150
– –
TWLO icon
1480
Twilio
TWLO
$29.1B
$3K ﹤0.01%
10
-122
-92% -$44.4K
UPST icon
1481
Upstart Holdings
UPST
$2.58B
$3K ﹤0.01%
+10
New +$1.97K
VSTM icon
1482
Verastem
VSTM
$532M
$3K ﹤0.01%
83
– –
VYNE icon
1483
VYNE Therapeutics
VYNE
$17M
$3K ﹤0.01%
142
-154
-52% -$5.97K
WSM icon
1484
Williams-Sonoma
WSM
$26.7B
$3K ﹤0.01%
40
-88
-69% -$7.45K
WW
1485
DELISTED
WW International
WW
$3K ﹤0.01%
200
– –
XRX icon
1486
Xerox
XRX
$337M
$3K ﹤0.01%
179
– –
YEXT icon
1487
Yext
YEXT
$501M
$3K ﹤0.01%
300
– –
IRD
1488
Opus Genetics
IRD
$254M
$3K ﹤0.01%
600
– –
ARVL
1489
DELISTED
Arrival Ordinary Shares
ARVL
$3K ﹤0.01%
6
– –
SRNE
1490
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3K ﹤0.01%
500
– –
VLDR
1491
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$3K ﹤0.01%
600
– –
AKUS
1492
DELISTED
Akouos Inc
AKUS
$3K ﹤0.01%
300
– –
AGTC
1493
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3K ﹤0.01%
+1,000
New +$3.56K
TPGY
1494
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$3K ﹤0.01%
300
– –
GSAH.WS
1495
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$3K ﹤0.01%
+1,610
New +$3.13K
OPTU
1496
Optimum Communications Inc
OPTU
$316M
$2K ﹤0.01%
100
– –
BFH icon
1497
Bread Financial
BFH
$4.21B
$2K ﹤0.01%
35
– –
CCRD
1498
DELISTED
CoreCard
CCRD
$2K ﹤0.01%
50
– –
CGAU
1499
Centerra Gold
CGAU
$3.22B
$2K ﹤0.01%
395
– –
CSTE icon
1500
Caesarstone
CSTE
$72.3M
$2K ﹤0.01%
200
– –
58 59
60
61 62

Similar funds

MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

First Manhattan's Q3 2021 Portfolio in Review

As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
  • First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
  • First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
  • First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
  • First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
  • First Manhattan opened 132 new positions and closed 93 in Q3 2021.
  • First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.